A Phase II Study of Obinutuzumab and Lenalidomide in Previously Untreated Subjects With Follicular Lymphoma
Phase of Trial: Phase II
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Lenalidomide (Primary) ; Obinutuzumab (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 06 Dec 2016 Status changed from not yet recruiting to recruiting.
- 14 Oct 2016 Planned primary completion date changed from 1 Oct 2019 to 1 Dec 2019.
- 14 Oct 2016 Planned initiation date changed from 1 Oct 2016 to 1 Dec 2016.